These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6132566)

  • 1. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) and pancuronium in anesthetized humans.
    Cronnelly R; Fisher DM; Miller RD; Gencarelli P; Nguyen-Gruenke L; Castagnoli N
    Anesthesiology; 1983 May; 58(5):405-8. PubMed ID: 6132566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults.
    Rupp SM; Castagnoli KP; Fisher DM; Miller RD
    Anesthesiology; 1987 Jul; 67(1):45-9. PubMed ID: 2886080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of Org NC 45 in man.
    van der Veen F; Bencini A
    Br J Anaesth; 1980; 52 Suppl 1():37S-41S. PubMed ID: 6107104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children.
    Meistelman C; Agoston S; Kersten UW; Saint-Maurice C; Bencini AF; Loose JP
    Anesth Analg; 1986 Dec; 65(12):1319-23. PubMed ID: 2877596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
    Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
    Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis.
    Lebrault C; Berger JL; D'Hollander AA; Gomeni R; Henzel D; Duvaldestin P
    Anesthesiology; 1985 May; 62(5):601-5. PubMed ID: 2859815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.
    Fahey MR; Morris RB; Miller RD; Nguyen TL; Upton RA
    Br J Anaesth; 1981 Oct; 53(10):1049-53. PubMed ID: 6117300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.
    Williams A; Gyasi H; Melloni C; Bevan DR
    Can Anaesth Soc J; 1982 Nov; 29(6):567-72. PubMed ID: 6128068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vecuronium kinetics and dynamics in anesthetized infants and children.
    Fisher DM; Castagnoli K; Miller RD
    Clin Pharmacol Ther; 1985 Apr; 37(4):402-6. PubMed ID: 2858278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during cesarean section.
    Dailey PA; Fisher DM; Shnider SM; Baysinger CL; Shinohara Y; Miller RD; Abboud TK; Kim KC
    Anesthesiology; 1984 Jun; 60(6):569-74. PubMed ID: 6145374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans.
    Rupp SM; Miller RD; Gencarelli PJ
    Anesthesiology; 1984 Feb; 60(2):102-5. PubMed ID: 6141748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vecuronium in alcoholic liver disease: a pharmacokinetic and pharmacodynamic analysis.
    Arden JR; Lynam DP; Castagnoli KP; Canfell PC; Cannon JC; Miller RD
    Anesthesiology; 1988 May; 68(5):771-6. PubMed ID: 2897176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of vecuronium and pancuronium in cats with and without ligated renal pedicles.
    Booij LH; Vree TB; Van de Pol F; Crul JF
    Acta Anaesthesiol Belg; 1982; 33(3):157-65. PubMed ID: 6128859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat.
    Marshall IG; Gibb AJ; Durant NN
    Br J Anaesth; 1983 Aug; 55(8):703-14. PubMed ID: 6136285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia.
    Fisher DM; Miller RD
    Anesthesiology; 1983 Jun; 58(6):519-23. PubMed ID: 6134483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vecuronium induced neuromuscular blockade. The effect of increasing dose on speed of onset.
    Casson WR; Jones RM
    Anaesthesia; 1986 Apr; 41(4):354-7. PubMed ID: 2871770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.